Confluence Genetics today announced the launch of Cas-CLEAR™, Collaterally Enhanced Activated Ribonuclease, a new CRISPR technology plat ...
New data shows foundations are overwhelmed with funding requests but most are not moving more money. A reckoning on who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results